McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
Mr. Brian Tyler es el Chief Executive Officer de McKesson Corp, se unió a la empresa desde 2012.
¿Qué tal es el rendimiento del precio de la acción MCK?
El precio actual de MCK es de $890.96, ha aumentado un 0.57% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de McKesson Corp?
McKesson Corp pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de McKesson Corp?
La capitalización bursátil actual de McKesson Corp es $109.1B
¿Es McKesson Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 18 analistas han realizado calificaciones de análisis para McKesson Corp, incluyendo 7 fuerte compra, 12 compra, 3 mantener, 0 venta, y 7 fuerte venta